167 related articles for article (PubMed ID: 30719181)
1. Glucose-Regulated Protein 94 Modulates the Response of Osteosarcoma to Chemotherapy.
Huang CY; Wei PL; Wang JW; Makondi PT; Huang MT; Chen HA; Chang YJ
Dis Markers; 2019; 2019():4569718. PubMed ID: 30719181
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor promotes tumor progression and contributes to gemcitabine resistance in osteosarcoma.
Wang S; Wei H; Huang Z; Wang X; Shen R; Wu Z; Lin J
Acta Biochim Biophys Sin (Shanghai); 2021 Mar; 53(3):317-324. PubMed ID: 33432347
[TBL] [Abstract][Full Text] [Related]
3. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
Sun ZY; Jian YK; Zhu HY; Li B
Pathol Res Pract; 2019 Mar; 215(3):555-563. PubMed ID: 30661902
[TBL] [Abstract][Full Text] [Related]
4. Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells.
Tai CJ; Wang JW; Su HY; Tai CJ; Wang CK; Wu CT; Lien YC; Chang YJ
Tumour Biol; 2014 Jan; 35(1):403-10. PubMed ID: 23929391
[TBL] [Abstract][Full Text] [Related]
5. Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells.
Sun X; Wei Q; Cheng J; Bian Y; Tian C; Hu Y; Li H
Hum Cell; 2017 Jul; 30(3):216-225. PubMed ID: 28326487
[TBL] [Abstract][Full Text] [Related]
6. Wnt/β-catenin signaling pathway activation reverses gemcitabine resistance by attenuating Beclin1-mediated autophagy in the MG63 human osteosarcoma cell line.
Tao H; Chen F; Liu H; Hu Y; Wang Y; Li H
Mol Med Rep; 2017 Aug; 16(2):1701-1706. PubMed ID: 28656199
[TBL] [Abstract][Full Text] [Related]
7. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Xue HQ; Sun L; Sun C; Feng W; Guo SB
Oncol Rep; 2020 Apr; 43(4):1169-1186. PubMed ID: 32323781
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression.
Zhou Y; Zhao RH; Tseng KF; Li KP; Lu ZG; Liu Y; Han K; Gan ZH; Lin SC; Hu HY; Min DL
Acta Pharmacol Sin; 2016 Apr; 37(4):519-29. PubMed ID: 26924291
[TBL] [Abstract][Full Text] [Related]
10. Autophagy in osteosarcoma.
O'Farrill JS; Gordon N
Adv Exp Med Biol; 2014; 804():147-60. PubMed ID: 24924173
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
12. Silencing tumor-intrinsic HHLA2 potentiates the anti-tumoral effect of paclitaxel on MG63 cells: Another side of immune checkpoint.
Ahangar NK; Khalaj-Kondori M; Alizadeh N; Mokhtarzadeh A; Baghbanzadeh A; Shadbad MA; Dolatkhah K; Baradaran B
Gene; 2023 Mar; 855():147086. PubMed ID: 36535461
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
[TBL] [Abstract][Full Text] [Related]
14. Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma.
Kubota D; Mukaihara K; Yoshida A; Tsuda H; Kawai A; Kondo T
J Proteomics; 2013 Oct; 91():393-404. PubMed ID: 23911960
[TBL] [Abstract][Full Text] [Related]
15. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
Li D; Yang J; Ma H; Sun C; Feng R
J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
[TBL] [Abstract][Full Text] [Related]
16. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
[TBL] [Abstract][Full Text] [Related]
17. Tumor-oriented and chemo-photothermal nanoplatform capable of sensitizing chemotherapy and ferroptosis against osteosarcoma metastasis.
Wu H; Li B; Shao J; Kong Q
Int J Biol Macromol; 2024 Jun; 269(Pt 2):132019. PubMed ID: 38729498
[TBL] [Abstract][Full Text] [Related]
18. Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell.
Wang JY; Chen CM; Chen CF; Wu PK; Chen WM
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681897
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
Zhang Y; Duan G; Feng S
Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
[TBL] [Abstract][Full Text] [Related]
20. Effects of Kruppel-like factor 6 on osteosarcoma cell biological behavior.
Jianwei Z; Enzhong B; Fan L; Jian L; Ning A
Tumour Biol; 2013 Apr; 34(2):1097-105. PubMed ID: 23322324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
